David J. Giarracco
Chief Executive Officer
Dave joined Noninvasix in 2021 to make a difference in sepsis care by commercializing a noninvasive technology with the potential to detect sepsis sooner and safer while personalizing patient management. He is a commercial leader driving business growth and value, guiding organizations in launching revolutionary technologies into existing markets, leading acquisition/integration efforts, developing new markets, and improving organizational efficiency. He has successfully scaled organizations to exceed strategic plans by addressing commercial structure creating clinically focused solution selling organizations.
Donald Prough, M.D.
Clinical Vice President
Over 30 years experience in anesthesiology and critical care development and over 20 years experience in development and critical testing of systems for noninvasive monitoring. Dr. Prough is currently Rebecca Terry White Distinguished Chair and Professor of Anesthesiology and the Assistant Clinical Director of the Center for Biomedical Engineering at UTMB.